Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Marjatta Sinisalo"'
Autor:
Jyrki Taurio, Jenni Koskela, Marjatta Sinisalo, Antti Tikkakoski, Onni Niemelä, Mari Hämäläinen, Eeva Moilanen, Manoj Kumar Choudhary, Jukka Mustonen, Pasi Nevalainen, Ilkka Pörsti
Publikováno v:
Blood Pressure, Vol 32, Iss 1 (2023)
Purpose High sodium intake is an accepted risk factor for hypertension, while low Na+ intake has also been associated with increased risk of cardiovascular events. In this cross-sectional study, we examined the association of 24-h urinary Na+ excreti
Externí odkaz:
https://doaj.org/article/18b8f030bd9847cbbad758985d225946
Autor:
Sohvi Kääriäinen, Jukka Ollgren, Timothee Dub, Outi Laine, Marjatta Sinisalo, Jussi Hepojoki, Tomas Strandin, Eliisa Kekäläinen, Jussi Sane, Outi Lyytikäinen
Publikováno v:
International Journal of Infectious Diseases, Vol 131, Iss , Pp 1-6 (2023)
Objectives: The Puumala virus (PUUV) is a hantavirus that causes hemorrhagic fever with renal syndrome. Studies showing an increased risk of lymphoid malignancies after hantavirus infection, together with the observation that PUUV infects B cells, mo
Externí odkaz:
https://doaj.org/article/cbb173e785ff4836ae827c62354763b4
Autor:
Helena Hohtari, Niels Pallisgaard, Matti Kankainen, Pekka Ellonen, Oscar Brück, Timo Siitonen, Marjaana Säily, Marjatta Sinisalo, Marja Pyörälä, Maija Itälä-Remes, Perttu Koskenvesa, Erkki Elonen, Satu Mustjoki, Kimmo Porkka
Publikováno v:
Haematologica, Vol 107, Iss 8 (2022)
Externí odkaz:
https://doaj.org/article/5387630602a9470ab1aafc96dd4f32f5
Autor:
Vesa Lindström, Janne Aittoniemi, Urpu Salmenniemi, Helena Käyhty, Heini Huhtala, Marjatta Sinisalo
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 12, Pp 2910-2913 (2019)
The 23-valent pneumococcal polysaccharide vaccine (PPV23) given alone is ineffective in patients with chronic lymphocytic leukemia (CLL) and better antibody response is achieved with pneumococcal conjugate vaccines (PCVs). In this study, we determine
Externí odkaz:
https://doaj.org/article/9c1ec68a5ffa4213a8687d6a530de61b
Autor:
Vesa Lindström, Janne Aittoniemi, Urpu Salmenniemi, Helena Käyhty, Heini Huhtala, Maija Itälä-Remes, Marjatta Sinisalo
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 14, Iss 6, Pp 1471-1474 (2018)
Patients with chronic lymphocytic leukemia (CLL) are at a high risk for infections caused by Streptococcus pneumoniae. A pneumococcal conjugate vaccine (PCV) can induce a significant antibody response for some CLL patients. In this study we investiga
Externí odkaz:
https://doaj.org/article/be5d4bcbfddb4bd0a76dbdace697f96b
Autor:
Kari Remes, Pekka Anttila, Raija Silvennoinen, Mervi Putkonen, Hanna Ollikainen, Venla Terävä, Marjatta Sinisalo, Kristiina Kananen, Frida Schain, Päivi Castren-Kortegangas, Tiina M Järvinen, Marta Pisini, Felix Wahl, Tricia Dixon, Amy Leval
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0208507 (2018)
Outcomes for patients with multiple myeloma (MM) have improved with the advent of novel therapies, however, real-world evidence of outcomes in clinical practice is scarce. We conducted a multi-center registry study to build a reliable picture of trea
Externí odkaz:
https://doaj.org/article/11689cf4afe845ac9bd414f022a2ebe9
Autor:
Gordon Cook, Simona Iacobelli, Anja van Biezen, Dimitris Ziagkos, Veronique LeBlond, Julie Abraham, Grant McQuaker, Stefan Schoenland, Alessandro Rambaldi, Kazimierz Halaburda, Maria Rovira, Simona Sica, Jenny Byrne, Ramon Garcia Sanz, Arnon Nagler, Niels W.C.J. van de Donk, Marjatta Sinisalo, Mark Cook, Nicolaus Kröger, Theo De Witte, Curly Morris, Laurant Garderet
Publikováno v:
Haematologica, Vol 102, Iss 1 (2017)
POEMS syndrome is a rare para-neoplastic syndrome secondary to a plasma cell dyscrasia. Effective treatment can control the disease-related symptom complex. We describe the clinical outcome of autologous stem cell transplantation for patients with PO
Externí odkaz:
https://doaj.org/article/de22ba25e3484af89e6d10c27117e840
Autor:
Anna Kreutzman, Peter Rohon, Edgar Faber, Karel Indrak, Vesa Juvonen, Veli Kairisto, Jaroslava Voglová, Marjatta Sinisalo, Emília Flochová, Jukka Vakkila, Petteri Arstila, Kimmo Porkka, Satu Mustjoki
Publikováno v:
PLoS ONE, Vol 6, Iss 8, p e23022 (2011)
Before the era of tyrosine kinase inhibitors (TKIs), interferon-alpha (IFN-α) was the treatment of choice in chronic myeloid leukemia (CML). Curiously, some IFN-α treated patients were able to discontinue therapy without disease progression. The ai
Externí odkaz:
https://doaj.org/article/6dd371f4b6b64bb396523e3f23e118ab
Autor:
Timo Siitonen, Timo Timonen, Eeva Juvonen, Venla Terävä, Anu Kutila, Tuomo Honkanen, Maija Mikkola, Heikki Hallman, Marjut Kauppila, Pirkko Nyländen, Eira Poikonen, Auvo Rauhala, Marjatta Sinisalo, Merja Suominen, Eeva-Riitta Savolainen, Pirjo Koistinen
Publikováno v:
Haematologica, Vol 92, Iss 8 (2007)
Valproic acid (VPA), an inhibitor of histone deacetylases, inhibits the growth of leukemia cells and induces their differentiation in vitro. In the present study, VPA in combination with two differentiating agents, 13-cis retinoic acid and 1,25-dihyd
Externí odkaz:
https://doaj.org/article/9c3c31a9b98443a3a4d3779322544994
Autor:
Marjatta Sinisalo, Kimmo Porkka
Publikováno v:
European Journal of Haematology. 109:257-270